The following is a summary of “Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and ...

“Advanced therapies represent an important option in the treatment of plaque psoriasis, but as a physician, it’s critically important to continually assess if patients are having an optimal ...

In people with light skin tones, plaque psoriasis is characterized by raised ... I got ghosted for a reality TV dating show spot, and my confidence tanked. About five years ago, I was trying ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Though approved for moderate or severe plaque psoriasis, "for me, I think the sweet spot in terms of treating patients with moderate to severe plaque psoriasis is a bit more toward the moderate ...

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Fast Five Quiz: Plaque Psoriasis Management How much do you know about the management of plaque psoriasis? Test your knowledge with this quick quiz. Medscape, April 09, 2025 Study Links Obesity to ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Johnson & Johnson (J&J) has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating moderate-to-severe plaque psoriasis (PsO). The data revealed ...

Deucravacitinib offers another potential example for optimization. Though approved for moderate or severe plaque psoriasis, "for me, I think the sweet spot in terms of treating patients with moderate ...